Quantum Cyber N.V. Reports No Revenue and Increased Losses Amid Strategic Transition

Quantum Cyber N.V., formerly known as Mainz Biomed N.V., has reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2026. The company recorded no revenue during the quarter, consistent with the previous year, as it transitions away from its legacy business in colorectal cancer diagnostics to focus on developing technologies in the quantum cybersecurity and drone sectors. The total operating expenses for the quarter surged to $9.9 million, a 507% increase from $1.6 million in the same period last year, primarily driven by substantial investments in research and development, which reached $4.6 million compared to $101,000 in the prior year.

The company’s net loss for the quarter was $11 million, compared to a loss of $3.5 million in the same quarter of 2025, reflecting a 217% increase in losses. This increase is attributed to heightened operational costs associated with the launch of its new business initiatives, including a significant $4.3 million in-process research and development expense related to the acquisition of quantum antenna technology. The comprehensive loss for the quarter was reported at $10.4 million, indicating a substantial financial strain as the company pivots its strategic focus.

In terms of operational changes, Quantum Cyber N.V. has made notable strategic shifts, including the divestiture of its colorectal cancer screening business, which was officially closed in February 2026. The company has since entered into agreements to sell related assets, including the ColoAlert product line, for a total of approximately $1.6 million. Additionally, the company has launched a new autonomous defense platform and secured exclusive licenses for drone technology, marking its entry into the drone manufacturing sector. The acquisition of a plant to support drone production was finalized in July 2026, further solidifying its commitment to this new direction.

The company’s balance sheet reflects a significant increase in total assets, which rose to $23.4 million as of June 30, 2026, up from $5.3 million at the end of 2025. This increase is largely due to cash reserves of $13.4 million, bolstered by recent financing activities, including $6 million from preferred stock sales and $15.2 million from the exercise of warrants. The total liabilities decreased to $3 million from $4.7 million, indicating improved financial positioning despite ongoing operational losses.

Looking ahead, Quantum Cyber N.V. faces challenges related to its ongoing transition and the need for additional capital to sustain operations. The company has indicated that it may pursue further financing through public or private offerings to support its strategic initiatives. Management remains optimistic about the potential of its new business focus, emphasizing the integration of artificial intelligence and quantum computing in developing advanced autonomous systems. However, the company acknowledges the uncertainty surrounding its ability to achieve profitable operations in the near term, given its accumulated deficit of approximately $121 million as of June 30, 2026.